feed,title,long_url,short_url
Benzinga,Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis,https://benzinga.com/general/biotech/21/09/23047076/incytes-topical-jak-inhibitor-scores-fda-approval-for-atopic-dermatitis,https://j.mp/3zrBRHf
Benzinga,This Analyst Sees 24% Upside In Ambarella - Read Why,https://benzinga.com/analyst-ratings/analyst-color/21/09/23046789/this-analyst-sees-24-upside-in-ambarella-read-why,https://j.mp/3tY5P4I
Benzinga,Bluebird Bio Files US Application For Î²-thalassemia Gene Therapy,https://benzinga.com/general/biotech/21/09/23046717/bluebird-bio-files-us-application-for-thalassemia-gene-therapy,https://j.mp/2ZmGlCT
Benzinga,Fast Track Status Expanded For Inventiva's NASH Treatment,https://benzinga.com/general/biotech/21/09/23046682/fast-track-status-expanded-for-inventivas-nash-treatment,https://j.mp/2XOvKQD
